John F. Newton

1.9k total citations
53 papers, 1.5k citations indexed

About

John F. Newton is a scholar working on Pharmacology, Pharmacology and Physiology. According to data from OpenAlex, John F. Newton has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 16 papers in Pharmacology and 11 papers in Physiology. Recurrent topics in John F. Newton's work include Pharmacogenetics and Drug Metabolism (18 papers), Drug-Induced Hepatotoxicity and Protection (13 papers) and Inflammatory mediators and NSAID effects (8 papers). John F. Newton is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Drug-Induced Hepatotoxicity and Protection (13 papers) and Inflammatory mediators and NSAID effects (8 papers). John F. Newton collaborates with scholars based in United States, United Kingdom and France. John F. Newton's co-authors include Jerry B. Hook, Glenn F. Rush, G. Barnard, William Collins, M W Gemborys, Chao-Hen Kuo, Jay Bernstein, Masahiro Yoshimoto, Henry M. Sarau and G H Mudge and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Geophysical Research Atmospheres and Analytical Biochemistry.

In The Last Decade

John F. Newton

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John F. Newton United States 26 462 331 218 178 161 53 1.5k
L R Pohl United States 23 747 1.6× 356 1.1× 218 1.0× 178 1.0× 211 1.3× 42 1.5k
Jackie L. Martin United States 26 923 2.0× 353 1.1× 227 1.0× 124 0.7× 176 1.1× 60 2.1k
Dennis V. Parke United Kingdom 23 699 1.5× 547 1.7× 233 1.1× 128 0.7× 147 0.9× 110 1.9k
H.H.W. Thijssen Netherlands 26 658 1.4× 301 0.9× 213 1.0× 241 1.4× 217 1.3× 97 2.4k
D. S. Davies United Kingdom 19 676 1.5× 323 1.0× 336 1.5× 137 0.8× 109 0.7× 38 1.3k
Dennis E. Drayer United States 29 525 1.1× 554 1.7× 252 1.2× 309 1.7× 62 0.4× 64 2.5k
Frederick J. Di Carlo United States 16 900 1.9× 473 1.4× 432 2.0× 191 1.1× 166 1.0× 63 1.8k
J G Kenna United Kingdom 19 605 1.3× 215 0.6× 163 0.7× 157 0.9× 158 1.0× 26 1.3k
B. K. Park United Kingdom 21 646 1.4× 259 0.8× 275 1.3× 340 1.9× 78 0.5× 39 1.6k
N.R. Kitteringham United Kingdom 18 641 1.4× 235 0.7× 241 1.1× 275 1.5× 114 0.7× 30 1.4k

Countries citing papers authored by John F. Newton

Since Specialization
Citations

This map shows the geographic impact of John F. Newton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Newton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Newton more than expected).

Fields of papers citing papers by John F. Newton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Newton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Newton. The network helps show where John F. Newton may publish in the future.

Co-authorship network of co-authors of John F. Newton

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Newton. A scholar is included among the top collaborators of John F. Newton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Newton. John F. Newton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Juan, Robert Van Horn, William R. Brian, et al.. (2002). Fondaparinux Sodium Is Not Metabolised in Mammalian Liver Fractions and Does Not Inhibit Cytochrome P450-Mediated Metabolism of Concomitant Drugs. Clinical Pharmacokinetics. 41(Supplement 2). 19–26. 25 indexed citations
3.
Newton, John F., et al.. (1999). Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column. Journal of Pharmaceutical and Biomedical Analysis. 19(3-4). 429–434. 33 indexed citations
4.
Newton, John F., et al.. (1998). High throughput liquid chromatography/mass spectrometry bioanalysis using 96-well disk solid phase extraction plate for the sample preparation. Rapid Communications in Mass Spectrometry. 12(2). 75–82. 87 indexed citations
5.
Newton, John F., et al.. (1997). Determination of SR 49059 in human plasma and urine by LC-APCI/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 15(12). 1913–1922. 7 indexed citations
6.
Tiller, Philip R., Jae C. Schwartz, Ian Jardine, et al.. (1997). Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system. Journal of Chromatography A. 771(1-2). 119–125. 26 indexed citations
7.
Hay, Douglas W.P., Roseanna M. Muccitelli, Lynne M. Vickery‐Clark, et al.. (1991). Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig. Pulmonary Pharmacology. 4(3). 177–189. 6 indexed citations
8.
Newton, John F., et al.. (1990). Oral and intravenous pharmacokinetics of the peptidoleukotriene receptor antagonists SK&F S-106203 and 104353. European Journal of Pharmacology. 183(5). 1872–1873. 2 indexed citations
9.
Egan, J., D.E. Griswold, Leonard M. Hillegass, et al.. (1989). Selective antagonism of peptidoleukotriene response does not reduce myocardial damage opr neutrophil accumulation following coronary artery occlusion with reperfusion. Prostaglandins. 37(5). 597–613. 9 indexed citations
11.
Torphy, Theodore J., John F. Newton, Martin A. Wasserman, et al.. (1989). The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 430–437. 3 indexed citations
12.
Straub, Kenneth, et al.. (1988). Determination of microsomal lauric acid hydroxylase activity by HPLC with flow-through radiochemical quantitation. Analytical Biochemistry. 170(1). 83–93. 29 indexed citations
13.
Griswold, Don E., Paul Marshall, Edward F. Webb, et al.. (1987). SK&F 86002: A structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochemical Pharmacology. 36(20). 3463–3470. 68 indexed citations
14.
Newton, John F., et al.. (1986). Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.. Journal of Pharmacology and Experimental Therapeutics. 237(2). 519–24. 45 indexed citations
15.
Hogaboom, G. Kurt, M. N. Cook, John F. Newton, et al.. (1986). Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.. Molecular Pharmacology. 30(6). 510–519. 85 indexed citations
17.
Ackermann, Bradley L., J. Throck Watson, John F. Newton, Jerry B. Hook, & W. Emmett Braselton. (1984). Application of fast atom bombardment mass spectrometry to biological samples: Analysis of urinary metabolites of acetaminophen. Journal of Mass Spectrometry. 11(10). 502–511. 30 indexed citations
18.
Doolittle, David J., John F. Newton, & Jay I. Goodman. (1983). Quantitative studies on metabolic activation in vitro employing benzo[a]pyrene as the test compound. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 108(1-3). 29–44. 3 indexed citations
19.
Newton, John F., G. Barnard, & William Collins. (1977). A rapid method for measuring menstrual blood loss using automatic extraction. Contraception. 16(3). 269–282. 121 indexed citations
20.
Newton, John F. & Peter Dixon. (1972). SITE OF ACTION OF CLOMIPHENE AND ITS USE AS A TEST OF PITUITARY FUNCTION. Obstetrical & Gynecological Survey. 27(6). 445–446. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026